Cargando…
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
Purpose: Meibomian gland disease is generally accepted as the leading cause for evaporative dry eye disease (DED). In a previous study, perfluorohexyloctane, a semifluorinated alkane, has been demonstrated to significantly increase tear film breakup time and to reduce corneal fluorescein staining in...
Autores principales: | Steven, Philipp, Augustin, Albert J., Geerling, Gerd, Kaercher, Thomas, Kretz, Florian, Kunert, Kathleen, Menzel-Severing, Johannes, Schrage, Norbert, Schrems, Wolfgang, Krösser, Sonja, Beckert, Michael, Messmer, Elisabeth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655475/ https://www.ncbi.nlm.nih.gov/pubmed/28922088 http://dx.doi.org/10.1089/jop.2017.0042 |
Ejemplares similares
-
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A Prospective, Multicenter Noninterventional Study
por: Steven, Philipp, et al.
Publicado: (2015) -
A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye
por: Gehlsen, Uta, et al.
Publicado: (2017) -
Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
por: Tsagogiorgas, Charalambos, et al.
Publicado: (2023) -
Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
por: Baudouin, Christophe, et al.
Publicado: (2016) -
Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome
por: Otto, Matthias, et al.
Publicado: (2021)